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Nonisotopic in situ hybridization is a powerful tool to 
analyze the Organization of complex genomes. Current 
approaches utilizing this technique for the analysis of 
linear and spatial genome organizations are presented. 
Clinical applications of these approaches, which open 
new avenues for diagnosis of disease-related chromo-
somal changes, are also discussed. 
Introduction 
The contiguous D N A string within a chromosome 
provides the basis for the linear Organization of 
the genetic material. Since the D N A extends 
roughly along the telomere-telomere axis of 
metaphase chromosomes, it is possible to order 
genes on the chromosomes. On the microscale, 
there is, however, the probability that the true 
spatial relationship of closely juxtaposed DNA se-
quences in metaphase chromosomes will be inde-
terminate, as the D N A is packaged in coiled su-
perstructures. In interphase cell nuclei the chro-
matin of individual chromosomes is localized in 
distinct territories (see below), yet, to date, little 
is known about the spatial Organization of the 
linear D N A molecule within such a chromosome 
domain. Since the interphase chromatin is more 
decondensed, a higher flexibility is expected with 
regard to the spatial Organization of neighboring 
D N A regions. 
The linear order of D N A segments within the 
genome can be established by a variety of 
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methods. The most direct approach for mapping 
D N A sequences is in situ hybridization, which 
can be used to visualize targeted D N A sequences 
both in metaphase chromosomes and in inter-
phase nuclei. Recently, nonisotopic in situ hy-
bridization has become increasingly populär for 
this purpose. The development of nonisotopic 
labels for nucleic acid probes as well as some gen-
eral applications of the methodology were re-
cently reviewed elsewhere [1, 2]. Here we will 
focus on the application of nonisotopic in situ hy-
bridization techniques in analyzing the linear and 
the spatial Organization of complex genomes and 
their use as a tool in clinical cytogenetics. Details 
of other applications will be presented elsewhere 
in this Journal [3-5]. 
Nonisotopic Labeling and 
Detection Systems 
Various methods can be used to label nucleic 
acids nonisotopically. For applications involving 
in situ hybridization, enzymatic incorporation of 
nucleotides modified with biotin [6-9], digoxi-
genin [10], dinitrophenol [6, 11] or halogenated 
nucleotides (e.g., BrdU, FrdU) is usually pre-
ferred over chemical labeling techniques em-
ploying photoreactive Compounds (photobiotin, 
photodigoxigenin, or photodinitrophenol) because 
of a higher labeling efficiency. However, other 
chemical modiftcation schemes using acetylami-
nofluorene [12], mercuration [13, 14], or sulfona-
tion [15] have been used successfully for sensitive 
nonradioactive detection of hybridized nucleic 
acid probes [16, 17]. Bound probes are also de-
tectable as part of D N A - R N A hybrids, which are 
recognized by specific antihybrid antibodies [18, 
19]. The visualization of hybridized probes can 
be achieved in several ways: (a) via fluoro-
chromes analyzed by fluorescence microscopy, 
(b) via chemiluminescence detected by an emul-
sion overlay or directly by photon-counting de-
vices (see below), or (c) via high-density colored 
precipitates generated by enzymatic assays or the 
use of metallic Compounds, such as colloidal gold 
or silver, for visualization by phase contrast, No-
marski, or electron microscopy. A l l of the 
methods outlined above generally use indirect de-
tection procedures. When fluorochromes are 
coupled directly to the probe molecules [20, and 
our own unpublished data], direct microscope ex-
amination of the signal is feasible. The sensitivity 
of each of the labeling/detection procedures re-
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ported by various laboratories has varied widely. 
This variability, at least in part, may reflect the 
quality of the reagents used or the degree to which 
experimental parameters were optimized. Biotin 
and digoxigenin labeling combined with fluores-
cent detection are currently the most widely used 
procedures, because of the high sensitivity of de-
tection and the commercial availability of the re-
agents. Fluorescent detection is generally pre-
ferred over enzymatic assays because of better 
spatial resolution, the ability to quantitate fluores-
cent signals by photon counting, and greater Po-
tential for simultaneous multiprobe analysis. 
The potential of nonisotopic in situ hybridiza-
tion procedures is significantly increased by mul-
tihybridization protocols enabling the simulta-
neous differential delineation of several target se-
quences. Whereas a large number of studies have 
included dual labeling techniques, recent develop-
ments in multiple fluorescence in situ hybridiza-
tion enable the simultaneous visualization of three 
or more D N A regions [21, 22]. 
Optical Instrumentation and 
Digital Imaging 
Refinements and new developments of optical In-
strumentation have also contributed significantly 
to the increased application of nonisotopic in situ 
hybridization techniques. Two features are of 
particular importance: the improved signal detec-
tion by increased sensitivity of optical instruments 
and the development of devices for three-dimen-
sional (3D) microscopy. Although most of the ad-
vancements are based on fluorescent or chemilu-
minescent detection Systems [23-25], the feasi-
bility of a 3D analysis of chromatin in interphase 
cell nuclei of higher organisms by using transmis-
sion light microscopy in combination with digital 
image analysis has been recently demonstrated 
[26-28]. 
Digital imaging techniques are more and more 
being used to Supplement conventional epifluo-
rescence microscopy [25, 29]. Several reasons 
account for this development: (a) Very weak fluo-
rescent signals can be documented more readily; 
image reproduction problems often occur when 
conventional photography is applied, (b) The po-
tential of image processing greatly facilitates the 
analysis of a labeled object. Optical filtering tech-
niques, such as thresholding, which enhances the 
signal to noise ratio, are particularly valuable. (c) 
Quantitative data on signal intensities or measure-
25 
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ments of inter- and intrasignal distances can be 
easily assessed. (d) Handling and storing of 
images are easy to perform (however, convenient 
handling of multimegabyte images requires appro-
priate Computer equipment). 
Digital imaging microscopy is performed using 
sensitive camera Systems or a laser Scanner 
equipped with a photomultiplier. The most sensi-
tive System to date, the cooled C C D (charged 
coupled device) camera, is a powerful instrument 
for biological research [30]. Because of its high 
efficiency in counting emitted photons over a 
broad spectral ränge of wavelengths, the C C D 
camera is the instrument of choice for two-dimen-
sional (2D) analyses, e.g., for the analysis of fluo-
rescent signals on metaphase chromosomes. 
However, when multiple images of a specimen are 
taken with different filter sets for multicolor anal-
ysis, each image must be registered accurately to 
guarantee the correct spatial presentation of over-
laid (composite) images. The image registration 
problem is not a trivial one; the development of 
methods for its Solution is an area of active re-
search. 
In 3D microscopy, a series of optical seciions 
through a labeled specimen is obtained. Three-di-
mensional reconstruction and analysis of the ob-
ject can be accomplished by applying appropriate 
Computer Software to a Stack of digitized images. 
There is a considerable amount of out-of-focus 
fluorescence in each section detected by conven-
tional image devices. High-quality optical sec-
tions for 3D microscopy require elimination of this 
out-of-focus fluorescence using sophisticated 
mathematical algorithms [31]. Laser scanning 
confocal microscopy [32-34] is designed to elimi-
nate most of the out-of-focus fluorescence prior to 
the optical detection device. In this way, optical 
sections of high quality are obtained directly, re-
ducing the amount of mathematical Operations re-
quired for 3D microscopy. In conclusion, com-
mercially available confocal laser scanning micro-
scopes can be used directly for both 2D and 3D 
digital imaging microscopy, whereas the available 
CCD camera Systems are superior in signal detec-
tion, but further development is required for rou-
tine application to 3D microscopy. 
Recent Developments in Nonisotopic in 
situ Hybridization 
The sensitivity of detecting nucleic acid target se-
quences nonisotopically has increased consider-
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ably over the past decade. Initially, small D N A 
probes could be readily used only when target se-
quences were present in higher copy numbers, as 
for example satellite D N A [35, 36], including al-
phoid repeats (for review, see [37]) or unique se-
quences on polytene chromosomes [38]. Düring 
the ensuing years, technical improvements were 
developed in numerous laboratories that en-
hanced the speed, reproducibility, and spatial res-
olution over that of the original autoradiographic 
procedures. Parameters influencing the hybrid-
ization efficiency and signal specificity were more 
precisely defined and optimized (e.g. [39-43]). 
Subsequent reports of mapping Single copy genes 
in genomes of high complexity varied in labeling 
efficiency. An increasing number of studies, how-
ever, has now demonstrated a highly specific de-
lineation of unique D N A in mammalian genomes 
[44-56]. Mapping of unique D N A of a com-
plexity as low as 1 kb has been reported. 
Considerably longer probes are likely to con-
tain interspersed repetitive sequences resulting in 
additional signals throughout the genome of 
higher organisms. Protocols designed to suppress 
the hybridization signals from these repetitive se-
quence elements by using appropriate competitor 
D N A have been published [57-59]. Total ge-
nomic D N A is easy to prepare and is usually suf-
ficient as competitor D N A . When high concen-
trations of competitor are needed, the Cotl D N A 
fraction [60] selectively enriched in highly repeti-
tive DNAs is preferred, because it does not com-
pete with the unique sequence fraction of the 
probe [57]. The suppression hybridization proce-
dure does not require the identification and isola-
tion of single-copy sequences within the probe, 
thus substantially decreasing the efforts necessary 
to map a genomic D N A fragment. This proce-
dura, which we refer to as chromosomal m situ 
suppression (CISS) hybridization, is being used to 
map mammalian sequences cloned in plasmid, 
bacteriophage, cosmid, or Y A C (yeast artificial 
chromosome) vectors [11, 57, 61-66]. An ex-
ample using YAC D N A is shown in Figure 1A. 
When complex probe sets, such as complete 
D N A libraries derived from sorted human chro-
mosomes, are used as probes [58, 59, 67], this 
technique is referred to as "chromosome 
painting" [59], since individual chromosomes or 
subchromosomal regions are visualized in a highly 
specific manner. 
Background may become a significant problem 
if a large fraction of D N A sequences in the probe 
Figure 1. Delineation of D N A sequences on human metaphase 
chromosomes and in interphase nuclei. A. A gel-purified YAC 
containing human D N A sequences (kindly provided by Terry 
Lerner, Integrated Genetics, Framingham, MA) was labeled 
with biotin and hybridized under suppression hybridization 
conditions to normal human chromosomes (46, XY). Detec-
tion via FITC-conjugated to avidin reveals the localization of 
the probe (see arrow) on the long arm of the X chromosome. 
Chromosomes are counterstained with propidium iodide. 
Chromosome identification was achieved by DAPI-banding 
(not shown). B. Characterization of a chromosomal break-
point within 11p. Metaphase of a somatic hybrid cell line con-
taining the relevant parts of the normal chromosome 11 as well 
as of the two derivatives of a translocation t(2;l 1) of a Potter's 
facies Syndrome patient, after hybridization with two cosmid 
probes of the central part of 11p. The probes, designated 
13-4A and 4-4B, were labeled with biotin and dinitrophenol 
and detected via FITC (arrowheads) and rhodamine (arrows), 
respectively. They are close together on the normal chromo-
some (near the center), but separated by the breakpoint as in-
dicated by the Single labels on each derivative chromosome 
(top and bottom). On each chromosome the target sites on 
both chromatids are labeled. The chromosomal counterstain 
is not shown, but the outline of the chromosomes is shown in 
the schematic drawing in B \ where the chromosome-11 mate-
rial is shown as shadowed region (in this particular subculture, 
the human chromosomes are not complete, as, for example, on 
the normal chromosome 11 the terminal portion of the short 
arm is missing). C - E . Simultaneous visualization of a fluo-
rescently labeled cosmid probe and chromosome banding. (C) 
Digoxigenin-labeled cosmid probe Jl-2 and a biotin-labeled 
D N A probe containing four Alu repeats were cohybridized and 
detected via rhodamine and FITC, respectively. Note the R-
banding-like pattern of the Alu probe signal. Chromosome 
identification and band assignment can be easily performed by 
using Alu banding. Cosmid Jl-2 had been mapped by FLpter 
values (see text) to a chromosome region corresponding to 
11p 11.2. This is indeed the cytological map position, as the 
signal is within the brightly stained band 1 lpl 1.2 (see arrows). 
(D) DAPI stain of the metaphase shown in C. Note that the 
DAPI stain is producing a G-banding pattern in heat-denatured 
chromosomes, even without further treatment (such as dista-
mycin). Whereas Alu probes do not label centromeres and 
several pericentromeric regions, the DAPI counterstain re-
veals the füll chromosome continuum (compare C and D). 
(E) Complete karyotype of the Alu-banded metaphase in C (46, 
XY). Note that the quality of the Alu banding is superior to 
the DAPI banding. F. Simultaneous visualization of the X-
chromosome domain (hybridization of digoxigenin-labeled X-
chromosome library DNA and detection via rhodamine) and 
the X-chromosomal gene for dystrophin (hybridization of 
biotin-labeled probe cpTl and detection via FITC, see arrows) 
in a normal female lymphocyte nucleus as well as in a meta-
phase plate, which is partly shown with one X chromosome 
(courtesy of Thomas Ried, Heidelberg, FRG). G and H . Posi-
tion of the subcentromeric heterochromatic region lql2 (hy-
bridization of acetylaminofluorene-labeled probe pUC1.77 and 
detection via rhodamine) and the telomeric band lp36 (hybrid-
ization of biotin-labeled probe pl-79 and detection via FITC) 
of human chromosome 1 in normal human fibroblasts (for 
methodological details see [147]). Note that the orientation 
and spatial extension of the short arm of chromosome 1 can be 
easily recognized in diploid (G) and tetraploid (H) nuclei after 
dual color interphase chromosome banding using these 
probes. The pictures in B - E are part of a collaborative study 
published recently [11], F is part of a study by Ried and co-
workers [159], and pictures in G and H are from a study by 
Thomas Cremer and Laura Manueüdis (Yale University) (un-
published). The digitized images ( A - E ) were obtained by 
using a confocal laser scanning microscope (A and B) or a 
cooled C C D camera (C-E) . The pictures in F - H were taken 
by conventional photography using a Standard epifluorescence 
microscope. 
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does not contribute to a specific signal, for ex-
ample in chromosome library D N A cloned in 
phage lambda Charon 4A [68], where the vector to 
insert ratio is large (e.g., 10:1), or in YAC D N A 
present in yeast cells in addition to a whole yeast 
genome complement. In such cases, it might be 
preferable to gel-purify the phage D N A inserts or 
the YAC D N A to eliminate lambda sequences or 
yeast D N A , respectively. Recently, new chromo-
some libraries have been constructed in plasmid 
vectors, where the vector to insert ratio is lowered 
[69], and these libraries may be preferable to the 
phage libraries, which have been used so far for 
chromosome painting. 
Cosmids are particularly useful probes, as they 
can delineate —90% of the target sites without sig-
nificant background noise. Thus, as applied to 
gene mapping (see below), almost every meta-
phase spread is informative, since most spreads 
give four signals (i.e., on both chromosome ho-
mologs and both chromatids). This greatly re-
duces the Statistical analysis required. As the 
probe complexity decreases, the percentage of 
delineated target sequences decreases as well. 
When the chromosomal target is smaller than ~2 
kb, the percentage of metaphases exhibiting 
highly specific signals is usually reduced to <50% 
(see, e.g., [55, 56]). Although a variety of high-
sensitivity in situ hybridization protocols have 
been published (for citations, see above; the pro-
cedures used in our laboratories are described ex-
plicitly in [11, 58, 70]), it is agreed that certain 
factors are critical for a successful hybridization. 
Problems arise mainly by neglecting one of the fol-
lowing factors: purity and concentration of the 
D N A template, control of the labeling reaction 
(such as labeling efficiency and the actual size of 
the probe molecules after the labeling), high-
quality preparations of chromosomes and nuclei, 
control of the conditions for optimal denaturation 
of the target D N A , and quality control of reagents 
used during the whole procedure. 
New Approaches for Generation of 
Probe Sets 
For many cytogenetic applications (see below), 
probe sets for chromosome painting at an inter-
mediate level, e.g., subchromosomal regions of 
one or more chromosome bands in length, would 
be preferable to D N A libraries from whole sorted 
chromosomes. Such probes are presently largely 
restricted to the centromeric and pericentromeric 
heterochromatin and some other blocks of tan-
demly repeated D N A located on the chromosome 
arms, but are still missing for most other chromo-
somal subregions. In this context, three ap-
proaches seem to be promising: (a) Contiguous 
cloned D N A covering long genomic regions, such 
as one or more YAC clones or sets of contiguous 
cosmids, respectively, will be increasingly avail-
able as part of the research in the human genome 
initiative, (b) D N A probe sets obtained by 
cloning microdissected chromosomal material can 
be used to paint desired chromosomal subregions 
of humans in a targeted fashion [71]. In addition, 
this method could in principle also be applied to 
delineate chromosomes and chromosomal subre-
gions of any species without the need to sort chro-
mosomes. (c) Somatic hybrid cell D N A can be 
used as a probe for chromosome painting. The 
total D N A of a hybrid cell line can be used under 
suppression hybridization conditions and hybrid-
ized back to normal metaphases of one "pa-
rentar' species, thus the chromosomal content of 
this species in the hybrid line is immediately ap-
parent [72, 73]. However, variable concentrations 
of species-specific D N A in hybrid lines as well as 
cross-homologies of certain sequences can affect 
the quality of such an analysis. To avoid these 
Problems, PCR ampliflcation of species-specific 
sequences in the hybrid D N A has been carried out 
by using species-specific oligomer primers tar-
geting interspersed repetitive D N A dements [74, 
75]. The resultant PCR products can be prepared 
at little expense and provide efficient probe sets 
for chromosome painting without the necessity of 
cloning [76, 77]. Careful selection of hybrid lines 
with small chromosomal fragments, such as radia-
tion-reduced or chemically reduced hybrids, will 
allow the generation of painting probes for a wide 
ränge of chromosomal subregions. 
Rapid Mapping of DNA Sequences 
The Utility of CISS hybridization in combination 
with digital imaging microscopy to map large 
numbers of genomic D N A fragments with speed 
and precision has been demonstrated [11]. For 
this, probes were ordered along a chromosome by 
using mapping coordinates defined by the fraction 
of the distance between the signal and a reference 
point (arbitrarily chosen as the end of the short 
arm of the chromosome, pter) to the total length 
of the chromosome (FLpter, fractional length of 
chromosome with reference point pter). It should 
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Nonisotopic in situ Hybridization 
29 
GATA 8(1): 24-35, 1991 
be noted that the ISCN banding ideograms [78] 
are not normalized relative to the fractional length 
of chromosomes, so that FLpter values cannot be 
extrapolated from these ideograms to give map 
coordinates as a band locus. This approach can 
be used however, to map the relative chromo-
somal position of multiple probes. The precision 
of this mapping strategy is greatly dependent on 
the condensation of the chromosome; signifi-
cantly greater resolution is obtained with elon-
gated (prometaphase) chromosomes. 
Parameters influencing the variability of chro-
mosomal length must be carefully considered, 
since chromatin condensation is nonuniform. 
Chromosome length polymorphisms must be 
taken into account when more than one chromo-
some homolog is analyzed, because such vari-
ability, e.g., of heterochromatin blocks, chromo-
some satellites, or even 4 'normal" interindividual 
length differences [79, 80], can be considerable. 
These potential limitations can be circumvented 
by using comparable chromosomes of one indi-
vidual [11] or by carefully measuring a variable 
region to normalize the linear measurements [55]. 
Inclusion of chromosome banding, the major 
means of identifying chromosomes, reduces the 
influence of length polymorphisms in the analysis, 
since selected smaller distances, defined by the 
border of bands, could be used as reference points 
[65]. Furthermore, the simultaneous banding in-
terlocks such mapping data in terms of classical 
cytogenetic terminology (see Figure 1C-E). With 
fluorescent signal detection, conventional Giemsa 
or Wright banding is time consuming, since the 
analysis of the signal and the banding is carried 
out in two consecutive Steps with separate Photo-
graphie processes. Simultaneous detection of 
chromosome banding by Giemsa staining, fol-
lowing BrdU incorporation and staining with 
Hoechst 33258, has been reported [46]. Banding 
methods that can be applied in parallel to fluores-
cence probe detection, and do not require a relo-
cation of chromosomes, are preferable. Chromo-
myein (modified from [45]), quinacrine (our own 
unpublished data), Hoechst 33258 [49], or DAPI 
banding [67, 81] (see, e.g., Figure 1D) are easily 
combined with the hybridization/detection proce-
dure. In our hands, differential staining of chro-
mosomes with propidium iodide, resulting in R 
banding, was of variable quality, but recent 
studies reported propidium iodide banding after 
BrdU incorporation and demonstrated the useful-
ness of this technique for mapping [82, 83]. Due 
to morphological changes during chromosome 
denaturation, the quality of subsequent banding 
may be variable and less than optimal. Fortu-
nately, alternative procedures are available. Rep-
lication banding following incorporation of BrdU 
into cellular D N A late in S phase [84], which gives 
predominantly an R-banding pattern, has been ap-
plied successfully in D N A mapping studies [27, 
65]. D N A probes for interspersed repetitive ele-
ments cause distinet banding patterns on meta-
phase chromosomes [11, 85, 86] and can be used 
to produce a simultaneous in situ hybridization 
banding profile. Alu repeats, which also generate 
an R-banding-like pattern [87-89], are very useful 
for human chromosome identification. Both 
cloned Alu sequences [11] and PCR produets gen-
erated from an Alu primer [86] have been re-
ported. An example of a cosmid mapping in com-
bination with Alu banding is shown in Figure 
1 C - E . To date, neither L I clones nor L I PCR 
produets have generated reproducible G banding 
in humans. In contrast, the L I sequence of 
mouse is particularly effective in generating a 
banding pattern very similar to Giemsa dark bands 
[85]. Interestingly, of the two major Alu-like re-
peat families in mouse D N A , only the B2 family 
gives a useful R-banding pattern on murine chro-
mosomes. 
Additional confirmation of chromosome as-
signment can be achieved by cohybridization with 
a probe or probe set known to map to the target 
chromosome of interest (preferably labeled in a 
different way). The latter approach is particularly 
useful when analyzing multiple clones derived 
from a monochromosomal hybrid cell line or from 
a chromosome library prepared after flow sorting. 
The relationship of two or more probes can be 
analyzed with higher resolution if the probes are 
hybridized simultaneously on the same chromo-
some using multicolor detection procedures [65, 
and our own unpublished results]. Another route 
to the rapid acquisition of mapping information is 
to exploit translocation chromosomes or panels of 
hybrid cell lines containing fragments of a Single 
chromosome of interest. Mapping a probe on 
rearranged chromosomes [90] in relation to known 
chromosomal breakpoints results in a quick yes or 
no answer regarding the relative order of probes 
[62]. An example of this is shown in Figure IB. 
To improve the mapping resolution further, 
chromosomal D N A can be analyzed in more de-
condensed states, as for example after premature 
chromosome condensation, chromosome shat-
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tering, or in interphase nuclei. The possibility 
that distances between two targets located at dif-
ferent sites of the same chromosome can be quan-
titatively assessed directly in interphase nuclei 
has first been demonstrated by Rappold and co-
workers using isotopic in situ hybridization [91]. 
Surprisingly, these and other data (see below) in-
dicated a considerably less decondensed State of 
interphase chromosomes than previously 
thought. More recently, "interphase chromatin 
mapping" has been dramatically improved using 
nonisotopic protocols for the mapping of D N A 
probes separated by distances ranging from 30 kb 
up to ~1 Mb [47, 61, 65]. Following multiple dis-
tance measurements, the highest likelihood of 
probe order was established [61, 65], which was in 
complete agreement with mapping data obtained 
by other methods. In contrast, ordering probes 
on metaphase chromosomes is not based on dis-
tance measurement, but on ordering along the 
longitudinal axis of the chromosome. Although 
simultaneously hybridized probes as close to each 
other as 100 kb reveal spatially resolvable signals 
such probes cannot be ordered along the longitu-
dinal axis of chromosomes, since they usually 
occur within the same latitude of a chromatid. 
Analyzing multiple paired signals, we have been 
able to order probes on chromosomes in the 1-Mb 
ränge (unpublished data), whereas others were 
unable to establish an order at that resolution 
[65]. This might reflect the fact that the 1-Mb 
ränge represents the border of resolution for meta-
phase mapping and the resolution might be in-
fluenced not only by chromosome length, but also 
by variations of chromatin conformation at dif-
ferent chromosomal sites. Mapping resolution of 
interphase and metaphase chromatin is further de-
scribed elsewhere [5]. 
Finally, it should be mentioned that CISS hy-
bridization provides an extremely powerful tool 
for the comparative mapping of individual se-
quences contained in cosmid or YAC clones (our 
unpublished data). In addition, blocks of genetic 
material that are syntenic to humans can be iden-
tified unequivocally in other primate species by 
chromosome painting with D N A libraries from 
sorted human chromosomes or appropriate re-
gional probe sets [92]. 
Nuclear Topography 
Although early cytologists such as Carl Rabl, 
Theodor Boveri, and Eduard Strasburger sug-
gested a territorial Organization of interphase 
chromosomes (for review, see [93]), this view was 
disputed in the 1960s and early 1970s. By this 
time, it had become obvious that the length of the 
chromatin fiber constituting an individual chromo-
some exceeds the diameter of the nucleus many-
fold. Accordingly, extremely different types of 
arrangements of such a fiber can theoretically be 
envisaged. More importantly, electron micro-
scopic studies of cell nuclei had failed to distin-
guish individual chromosome domains [94, 95]. 
Unequivocal evidence for the existence of a terri-
torial interphase chromosome Organization in so-
matic mammalian cell nuclei was provided by 
laser microbeam studies [96-98] and more re-
cently by in situ hybridization experiments. Indi-
vidual chromosome domains have been directly 
visualized in cell nuclei of interspecies mamma-
lian somatic hybrid cells after in situ hybridization 
with total genomic D N A of one species [42, 
99-102]. Preliminary 3D analyses of complete 
human chromosomes in somatic hybrid cell nuclei 
have been reported [103, 104]. The painting of in-
dividual chromosomes in normal and aneuploid 
cells further established that the same territorial 
Organization of chromosomes occurs in nonhybrid 
cells [58, 59, 67] (see Figure 1F). In situ hybrid-
ization experiments have also confirmed a territo-
rial interphase chromosome Organization for plant 
species [105, 106]. 
Nonradioactive in situ hybridization to specific 
chromosome targets and 3D microscopy have 
been recently applied by several groups for the 3D 
analysis of the nuclear topography in human cells 
[27, 104, 107-109]. Delineation of the hetero-
chromatic region 1 q 12 in different human cell 
types serves as an illustrative example of how the 
concept of cell-type-specific chromatin arrange-
ments is presently being tested (see Figure IG and 
H). Manuelidis and Borden [27] using a 3D ap-
proach observed that one 1 q 12 region was fre-
quently associated with the nucleolus in nuclei of 
large neurons, while the corresponding region of 
the homologous chromosome was found to be ei-
ther associated with the nucleolus as well, or with 
the nuclear periphery. In glial cell nuclei, how-
ever, both lql2 regions were generally associated 
with the nuclear envelope. Two-dimensional 
analyses of the relative arrangements of the two 
lql2 regions in nuclei of lymphocytes, amniotic 
fluid cells, and fibroblasts as performed by Em-
merich and coworkers [110] indicated a highly 
variable and possibly random arrangement. Van 
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Dekken and coworkers [108, 109] noticed in 3D 
analyses that the lql2 regions were preferentially 
associated with the nuclear envelope of spherical 
and Polymorphie hemopoietic nuclei. Again the 
relative positions of the two regions in the pe-
riphery of spherical nuclei could not be distin-
guished from a random distribution pattern. In 
contrast, Arnoldus and coworkers [111], using a 
2D approach, observed a clear spatial association 
of the two regions in most nuclei of human cere-
bellum, but not in nuclei of human cortex. While 
these data collections may appear disparate, they 
could reflect a variable but cell-type-specific ar-
rangement of chromatin. 
The idea of a functionally important role of in-
tranuclear positioning of chromatin at various 
levels in replication, transcription, and differen-
tiation has been debated extensively (for reviews 
and discussion, see [94, 112-125]). Three sets of 
observations seem to be of particular interest in 
this context. First, terminal differentiation of 
cells may be correlated with specific chromatin 
movements within the cell nucleus [126-130]. 
Second, the 3D strueture and arrangement of 
chromatin may also be altered by pathological in-
fluences [28, 131-133]. Third, recent evidence 
has suggested the nonrandom distribution of 
nonchromosomal nuclear struetures, such as RNP 
particles [134]. In addition, fluorescence in situ 
hybridization experiments have demonstrated that 
R N A transcripts are accumulated and transported 
in a topologically highly ordered manner [135, 
136]. 
In general, the extent to which DNA domain 
Organization—DNA loops of up to many hundred 
kilobases in length, heterochromatin blocks, nu-
cleoli, telomeres and centromeres, chromosome 
bands, or even complete chromosomes—influ-
ences fundamental nuclear processes is still ill de-
fined. Mathog and Sedat [137] have concluded 
that the observed Organization of polytene chro-
mosomes in salivary gland nuclei is inconsistent 
with the idea that position of the chromosomes in 
the polytene nucleus plays a major role in the 
normal genetic regulation of euchromatic loci. 
However, comprehensive data for many cell types 
in various species are needed before a general pic-
ture may emerge. 
The Interpretation of data obtained by in situ 
hybridization and 3D microscopy has to take into 
aecount inherent methodological limitations. 
First, it is still not known to what extent chro-
matin distributions observed after various fixation 
and in situ hybridization procedures reflect the in 
vivo Situation. Second, in spite of great improve-
ments in 3D microscopy of chromosomes 
[137-139], there are still limitations that impair 
the precision with which the shape, size, and dis-
tribution of intranuclear chromosome targets can 
be measured. Third, it is far from trivial to create 
3D models of chromosome distribution in order to 
decide for or against a random distribution. De-
spite these difficulties, we expect that the ability 
to visualize virtually any chromosomal region in 
cell nuclei by in situ hybridization, and further ad-
vancements of 3D microscopy, will greatly en-
hance our knowledge about the Organization of 
the cell nucleus in the near future. 
Clinical Applications 
In spite of the present uncertainties concerning 
the finite intracellular Organization of chromatin, 
the fact that the D N A of each chromosome can be 
recognized as a distinet entity in the cell nucleus 
offers the opportunity to exploit in situ hybridiza-
tion for the evaluation of chromosome aberrations 
not only in mitotic cells, but also in cycling or 
noncycling interphase cells, and even in termi-
nally differentiated cells. Examples of some re-
cent applications in clinical cytogenetics, prenatal 
diagnosis, and the evaluation of the carrier Status 
of disease genes will be discussed below. Tumor 
cytogenetics, one of the most promising fields of 
application, will be discussed in more detail else-
where (T. Cremer et al . , in preparation). For 
other applications such as chromosome aberration 
detection in biological dosimetry [140-143], the 
reader is referred to the literature. 
The coneept of analyzing chromosome aberra-
tions in interphase nuclei started with the detec-
tion of numerical aberrations of the sex chromo-
somes by staining of the Barr and Y bodies, re-
spectively [144, 145]. The use of chromosome 
D N A probes to generalize this coneept has been 
termed "interphase cytogenetics" [146]. A l -
though the number of chromosomes that can be 
analyzed simultaneously is limited to the number 
of different reporter/detector combinations avail-
able, a distinet advantage of the method is that it 
can be carried out in cases where metaphase chro-
mosomes are difficult, if not impossible, to pre-
pare, as for example in the case of material from 
many solid tumors. 
Chromosome-specific repetitive D N A probes 
are ideal for the detection of aneuploidies, be-
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cause they label their target regions with very high 
efficiencies and the focal signals can be easily 
evaluated in metaphase as well as in interphase 
nuclei by conventional microscopy [21, 22, 
146-155]. For example, these probes have been 
used to detect aneuploidies in amniotic fluid cells 
of trisomies (e.g., trisomy 18) and aneuploidies of 
specific tumors such as gliomas, bladder and 
breast carcinomas, and various leukemias. How-
ever, for the detection of structural changes, the 
repetitive probes are of limited use. 
Chromosome painting is a more powerful tool 
for the analysis of structural chromosome aberra-
tions. It is very often extremely difficult to assign 
small pieces of rearranged chromosomal material 
by banding techniques, whereas painting of the 
chromosome in question visualizes even small 
translocated material of the targeted chromosome 
[156]. Chromosome painting can be used for de-
tecting numerical as well as structural aberrations 
of a particular chromosome (e.g., chromosome 21 
aberrations diagnostic for Down's Syndrome) [48, 
59, 67, 69, 157]. 
Smaller D N A probes are very useful for the 
analysis of structural changes in defined chromo-
somal subregions. One of the most challenging 
tasks of cytogenetic analysis is the identification 
of small deletions, especially when they appear to 
be submicroscopic. Quantitative Southern blot 
analysis has been a means of detecting such dele-
tions. Alternative methods include analysis of 
large D N A fragments by using pulsed-field gel 
electrophoresis. Conventional isotopic in situ hy-
bridization using D N A probes relevant for a sus-
pected deleted region requires a Statistical anal-
ysis that does not distinguish between a deleted 
allele or a hybridization experiment of lower effi-
ciency. In contrast, the high efficiency of noniso-
topic in situ hybridization with cloned genomic 
D N A fragments permits such an analysis not only 
on metaphase chromosomes, but also in inter-
phase nuclei. The usefulness of this approach has 
been demonstrated for detecting a deletion of the 
ankyrin gene resulting in a subtype of hereditary 
spherocytosis [158] as well as for the demonstra-
tion of the carrier Status of women with deletions 
in the dystrophin gene [159]. Diagnostic applica-
tions for other genetic diseases including microde-
letions, such as retinoblastoma, DiGeorge's Syn-
drome, or the 4p-minus Syndrome, can be pre-
dicted. 
Single genomic probes are also successfully 
used for determining the representation of a par-
ticular chromosome band in a cell population. In 
certain diagnostic applications, such as the detec-
tion of trisomy 21, small probes are more informa-
tive than painting of whole chromosomes, be-
cause the more focal signals are easier to quanti-
tate [48, 160]. Furthermore, Single probes 
flanking or spanning a chromosomal breakpoint 
can be used to detect a diagnostically important 
breaking event [161-163] or to characterize fur-
ther a breakpoint region [11, 164, 165]. An ex-
ample of a breakpoint in the short arm of chromo-
some 11 from a Potter's facies Syndrome patient 
was previously reported and is shown in Figure 
IB. This approach seems particularly useful in 
analyzing specific translocations in blood cell 
tumors [162, 163, 165]. The details, implications, 
and prospects of this application of nonisotopic in 
situ hybridization are reviewed elsewhere in this 
Journal [3]. 
In summary, we have demonstrated here the 
various ways by which in situ hybridization is 
being applied to establish the genetic composition 
and Organization of complex genomes and how 
probe sets derived from such studies are being in-
creasingly applied to address important clinical 
questions. 
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